Medivir AB Sustainability Reports
Medivir AB develops innovative therapies targeting diseases with high unmet medical needs, with a primary focus on oncology. Its lead drug candidates are designed to treat advanced liver cancer and other rare clinical conditions.
Sector: Manufacturing
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300VWDGUX0WMJ1T79
FIGI: BBG001S9BMP9
25 reports from 2012 to 2025